课题基金 / 基金详情

Metabolic correlates of antidepressant response to ketamine and electroconvulsive therapy: A pilot FDG-PET study

Metabolic correlates of antidepressant response to ketamine and electroconvulsive therapy: A pilot FDG-PET study
氯胺酮和电休克治疗抗抑郁反应的代谢相关性：FDG-PET 试点研究
批准号：
458887
负责人：
Burhunduli Patricia
金额：
$7.65万
依托单位：
University of Ottawa Institute of Mental Health Research
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458887&lang=en
关键词：
Bipolar Disorder Electroconvulsive Therapy Intravenous Ketamine Magnetic Resonance Imaging Major Depressive Disorder Positron Emission Tomorgraphy Suicidal Ideation Treatment Resistant Depression

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Major depressive disorder (MDD) is the second leading cause of disability worldwide. Although there are effective treatments for depression, many patients do not achieve remission, and any significant response usually occurs after a few weeks. To date, th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金